首页> 外国专利> (The pernasality constituent which includes gurishirechin Acid is excluded,

(The pernasality constituent which includes gurishirechin Acid is excluded,

机译:(排除了包括古里津酸的鼻炎成分,

摘要

PURPOSE:To obtain a nasal composition having excellent absorption of a medicine from nasal mucosa, extremely low irritation and toxicity to tissue, high safety, capable of sufficiently maintaining pharmacodynamic effect and concentration of medicine in blood. CONSTITUTION:This nasal composition contains a pharmacodynamically active substance, water and an alcohol and the content of the alcohol is 10-70vol.%, especially 15-30vol.% based on the total of the composition. A 1-4C alcohol, a 2-5C alkanediol or a 3-6C alkanetriol is preferable as the alcohol and propylene glycol having its actual results of use as an additive of medicine is especially suitable. The amount of propylene glycol to be added is 15-30vol.%. A medicine having high initial passage effect especially in the liver, a medicine which has high water solubility and is not sufficiently absorbed by oral administration and a medicine extremely decomposing in digestive tract are preferable as the pharmacodynamically active peptide or a physiologically active protein may be cited as the pharmacodynamically active substance to be used.
机译:用途:获得具有从鼻粘膜极好的药物吸收,对组织的极低刺激性和毒性,高安全性,能够充分维持药效和血液中药物浓度的鼻用组合物。组成:该鼻用组合物含有药效学活性物质,水和醇,且基于组合物的总量,该醇的含量为10-70vol。%,尤其是15-30vol。%。作为醇和丙二醇,优选具有1-4C的醇,2-5C的链烷二醇或3-6C的链烷三醇,其实际结果用作药物添加剂是特别合适的。丙二醇的添加量为15〜30体积%。作为药物动力学活性肽或生理活性蛋白质,可列举出特别是在肝脏中具有较高的初期通过效果的药物,水溶性高,口服吸收不充分的药物,在消化道中极易分解的药物。作为要使用的药效学活性物质。

著录项

  • 公开/公告号JP3597233B2

    专利类型

  • 公开/公告日2004-12-02

    原文格式PDF

  • 申请/专利权人 久光製薬株式会社;

    申请/专利号JP19940279911

  • 发明设计人 迎 勝也;水町 充宏;伊藤 孝喜;

    申请日1994-10-19

  • 分类号A61K47/10;A61K9/08;A61K38/00;A61K38/04;

  • 国家 JP

  • 入库时间 2022-08-21 22:26:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号